europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

EU Industrial Strategy 2020: EuropaBio welcomes increased focus on competitiveness and resilience, driven by innovation and advanced technologies

06/05/2021
PRESS RELEASE
EU Industrial Strategy 2020: EuropaBio welcomes increased focus on competitiveness and resilience, driven by innovation and advanced technologies

EuropaBio response to the Communication on EU Industrial Strategy 2020

Brussels, 6 May 2021

Yesterday’s Communication on the updated 2020 Industrial Strategy is a positive development for companies working in the biotechnology sector.

Global challenges like COVID-19 and climate change require a range of solutions, including those coming from innovative biotechnology. Life sciences and biotechnology will play a transformative role in securing the EU’s competitive edge in health and sustainability.

“In the 14 months since the initial launch, the Industrial Strategy 2020 has been tested by COVID-19 for its ambition and robustness in building the Europe needed for our common future. EuropaBio is pleased to see a clear focus on priorities for European competences, competitiveness and leadership.’’- says Dr Claire Skentelbery, Director General of EuropaBio.

EuropaBio supports the development of key performance indicators which should allow the Commission to measure industrial ecosystems’ performance in terms of single market integration, productivity growth, international competitiveness, public and private investment, and R&D investment.

SMEs are the innovation engine needed to deliver novel technologies the future. EuropaBio, representing more than 2500 SMEs, knows the regulatory burdens that impact their development and prevent them from effective scaling up and market access. The increased attention from the Commission, with proposed actions to support of SMEs is a strong step in the right direction.

“Europe should seize the opportunity to invest in innovative manufacturing to achieve the desired goals of a healthier society, robust medicines supply chain, sustainable industrial production and a globally competitive position.
This helps European healthcare and industrial biotech applications to deliver their full potential, within robust and agile IP, digital and regulatory frameworks.”- says Dr Claire Skentelbery, Director General of EuropaBio


EuropaBio supports the Commission in working towards diversifying supply chains and pursuing international partnerships to increase crisis preparedness.

EuropaBio also welcomes the Important Projects of Common European Interest (IPCEIs) initiative in areas where the market alone cannot deliver breakthrough innovation, with possible support from the EU budget.

The updated Industrial Strategy could contribute to a more competitive EU biotechnology sector and enhance Europe’s open strategic autonomy.

EU Industrial Strategy 2020: EuropaBio welcomes increased focus on competitiveness and resilience, driven by innovation and advanced technologies


Download
Industrial Strategy_press release _DSDownload

Share
Alexandra Simionca
Alexandra Simionca

Related posts

23/05/2023

EuropaBio: Biomanufacturing and pharma legislation in the spotlight at the BIO International Convention 2023


Read more
23/05/2023

EUBA position on the European Commission’s Proposal for a Revised Packaging and Packaging Waste Regulation


Read more
10/05/2023

#EFIB2023 registration is now open: get your ticket today and benefit from the early bird fee


Read more
10/05/2023

Policy Proposal for New Genomic Techniques – Joint Letter to EU Vice-President Frans Timmermans and EU Commissioners Stella Kyriakides and Janusz Wojciechowski


Read more

Important links

  • SwedenBIO joins EuropaBio: helping innovative companies succeed!
  • Ajinomoto Europe joins EuropaBio: unlocking the power of amino acids

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies